Literature DB >> 26244922

α-Klotho is unstable in human urine.

Aaltje Y Adema1, Marc G Vervloet1,2, Marinus A Blankenstein3, Annemieke C Heijboer3.   

Abstract

α-Klotho is an interesting new biomarker in kidney and cardiovascular disease. As α-Klotho is primarily expressed in renal epithelial tissue, various papers have reported α-Klotho concentrations in urine. As these studies did not address the reliability of urinary α-Klotho measurements and as urine is known to be a complex milieu, we investigated the stability of α-Klotho in both fresh catheter and fresh voided urine. α-Klotho was measured in these fresh urine samples and in the same samples under several other conditions. Storage of fresh catheter urine for 3 h at 37 °C, comparable to storage in the bladder, led to a 82% decrease in α-Klotho concentrations. Compared with fresh voided urine, α-Klotho concentrations decreased on an average of 45 and 82% after storage at -80 °C and -20 °C, respectively. An additional freeze-thaw cycle further decreased α-Klotho concentrations. The addition of a protease inhibitor or 0.1% albumin partly prevented degradation in fresh voided urine. Thus, α-Klotho is highly unstable in urine. Future studies showing results of urinary α-Klotho should mention conservation conditions and prove the reliability of the α-Klotho measurements.

Entities:  

Year:  2015        PMID: 26244922     DOI: 10.1038/ki.2015.238

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.

Authors:  Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Makoto Kuro-o; Orson W Moe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

2.  Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects.

Authors:  Yuji Yamazaki; Akihiro Imura; Itaru Urakawa; Takashi Shimada; Junko Murakami; Yukiko Aono; Hisashi Hasegawa; Takeyoshi Yamashita; Kimihiko Nakatani; Yoshihiko Saito; Nozomi Okamoto; Norio Kurumatani; Noriyuki Namba; Taichi Kitaoka; Keiichi Ozono; Tomoyuki Sakai; Hiroshi Hataya; Shoji Ichikawa; Erik A Imel; Michael J Econs; Yo-Ichi Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  2010-07-01       Impact factor: 3.575

3.  Klotho deficiency causes vascular calcification in chronic kidney disease.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Carolyn Griffith; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

Review 4.  Pathophysiological implications of fibroblast growth factor-23 and Klotho and their potential role as clinical biomarkers.

Authors:  Javier Donate-Correa; Mercedes Muros de Fuentes; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  Clin Chem       Date:  2013-06-11       Impact factor: 8.327

5.  Laboratory aspects of circulating α-Klotho.

Authors:  Annemieke C Heijboer; Marinus A Blankenstein; Joost Hoenderop; Martin H de Borst; Marc G Vervloet
Journal:  Nephrol Dial Transplant       Date:  2013-06-19       Impact factor: 5.992

6.  Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.

Authors:  Tetsu Akimoto; Hiromichi Yoshizawa; Yuko Watanabe; Akihiko Numata; Tomoyuki Yamazaki; Eri Takeshima; Kana Iwazu; Takanori Komada; Naoko Otani; Yoshiyuki Morishita; Chiharu Ito; Kazuhiro Shiizaki; Yasuhiro Ando; Shigeaki Muto; Makoto Kuro-o; Eiji Kusano
Journal:  BMC Nephrol       Date:  2012-11-23       Impact factor: 2.388

  6 in total
  11 in total

Review 1.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

Review 2.  The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.

Authors:  Alexander Grabner; Christian Faul
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 3.  Klotho: A Major Shareholder in Vascular Aging Enterprises.

Authors:  Kenneth Lim; Arvin Halim; Tzong-Shi Lu; Alan Ashworth; Irene Chong
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

4.  Urine klotho is a potential early biomarker for acute kidney injury and associated with poor renal outcome after cardiac surgery.

Authors:  Yingying Qian; Lin Che; Yucheng Yan; Renhua Lu; Mingli Zhu; Song Xue; Zhaohui Ni; Leyi Gu
Journal:  BMC Nephrol       Date:  2019-07-17       Impact factor: 2.388

5.  No significant association of serum klotho concentration with blood pressure and pulse wave velocity in a Chinese population.

Authors:  Wan-Ying Liang; Li-Hong Wang; Jian-Hang Wei; Qing-Lu Li; Qi-Yan Li; Quan Liang; Nai-Qing Hu; Li-Hua Li
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

6.  Improving Science by Overcoming Laboratory Pitfalls With Hormone Measurements.

Authors:  Jacquelien J Hillebrand; Wjera V Wickenhagen; Annemieke C Heijboer
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

Review 7.  Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications.

Authors:  Javier A Neyra; Ming Chang Hu; Orson W Moe
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-22       Impact factor: 8.237

8.  Aging and sex affect soluble alpha klotho levels in bonobos and chimpanzees.

Authors:  V Behringer; J M G Stevens; T Deschner; R Sonnweber; G Hohmann
Journal:  Front Zool       Date:  2018-09-19       Impact factor: 3.172

Review 9.  Klotho, Aging, and the Failing Kidney.

Authors:  Sarah Buchanan; Emilie Combet; Peter Stenvinkel; Paul G Shiels
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-27       Impact factor: 5.555

Review 10.  Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.

Authors:  Marcella Liciani Franco; Stephany Beyerstedt; Érika Bevilaqua Rangel
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.